Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 2NIH 1NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Lymphoma 13Neuroblastoma 10Leukemia 9Central Nervous System Neoplasms 9Sarcoma 8Precursor Cell Lymphoblastic Leukemia-Lymphoma 8Brain Neoplasms 8Hodgkin Disease 5Burkitt Lymphoma 5Neuroectodermal Tumors, Primitive, Peripheral 4Lymphoma, Large B-Cell, Diffuse 4Dendritic Cell Sarcoma, Interdigitating 4Medulloblastoma 3Leukemia, Biphenotypic, Acute 3Astrocytoma 3Wilms Tumor 2Testicular Neoplasms 2Teratoma 2Rhabdomyosarcoma 2Rhabdoid Tumor 2Recurrence 2Osteosarcoma 2Myelodysplastic Syndromes 2Multiple Myeloma 2Malignant mesenchymal tumor 2Leukemia, Myeloid, Acute 2Leukemia, Monocytic, Acute 2Kidney Neoplasms 2Cardiotoxicity 2Carcinoma, Renal Cell 2

Interventions

Cyclophosphamide 5Epirubicin 4Docetaxel 4pegfilgrastim 2Trastuzumab 2Radiotherapy 2Filgrastim 2Doxorubicin 2Bevacizumab 2Taxes 1Surgical Procedures, Operative 1Paclitaxel 1Neoadjuvant Therapy 1Microarray Analysis 1Lapatinib 1Immunohistochemistry 1Granulocyte Colony-Stimulating Factor 1Fluorouracil 1Capecitabine 1Biopsy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Inflammatory Breast Neoplasms × Granulocyte Colony-Stimulating Factor × Clear all
NCT00016406 2013-01-24

S0012 Doxorubicin, Cyclophosphamide, and Paclitaxel With or Without Filgrastim in Treating Women With Inflammatory or Locally Advanced Breast Cancer

SWOG Cancer Research Network

Phase 3 Completed
399 enrolled
Breast

Breast Neoplasms, Inflammatory Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡